February 06, 2026 05:38 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Big call from RBI: Repo rate stays at 5.25%, neutral stance continues | RG Kar scam twist: Court issues non-bailable warrant against whistle-blower Akhtar Ali | Court snub for Vijay: Madras HC rejects plea in ₹1.5 crore tax case | ‘We never said no’: Suryakumar Yadav says India ready for Pakistan clash at T20 World Cup | Supreme Court orders Mamata govt to clear pending dues | ‘India is free to buy oil from anyone’: Russia fires back at Trump’s crude deal claim | ‘Justice crying behind closed doors’: Mamata Banerjee slams ECI in Supreme Court, CJI Kant assures solution | Mummy, Papa, sorry: Three sisters jump to death after parents object to online gaming | Supreme Court raps Meta, WhatsApp: ‘Theft of private information, won’t allow its use’ | ‘Completely surrendered’: Congress slams Modi after Trump’s trade deal move
Coronavirus Vaccine
Image Credit: Unsplash

UK kickstarts 'booster shot' trials with seven different Covid-19 vaccines: Report

| @indiablooms | May 20, 2021, at 07:03 am

London/IBNS: As fight against coronavirus is prolonged, mainly due to the more dangerous new variants of the contagion, the United Kingdom launched a nationwide study on Wednesday to find safety and efficacy of a third dose "booster" shot of Covid-19 vaccines in strengthening immunity against the deadly virus, according to a Reuters report.

The study will have 3,000 participants, who have already taken the two doses of coronavirus vaccine, and examine the effect of a third dose across seven different vaccines, the report said, adding that some of these vaccines are already in use while others are in the process of development.

The new study aims at exploring the possibility of a booster inoculation ahead of winter after initially targetting immunisation of the entire adult population with a two dose schedule by summer, the report informed.

The vaccines included in the trial are Pfizer, AstraZeneca and Moderna COVID-19 shots, which are already being administered in Britain, as well as vaccines from Johnson & Johnson, Novavax, Valneva and CureVac which the country will source in future, it said.

British health minister Matt Hancock said that the data accumulated in the trial will help shape the government to devise the plan for the booster programme later this year, the report added.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.